Pelthos Therapeutics Inc.

PTHS | AMEX

Price Alert Chart Builder DCF Calculator

$23.15

+$0.50 (+2.21%)

At close: Sep 21, 2026, 4:00 PM ET

$23.15

$0 (0.00%)

After-hours: Sep 21, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $80.46M

Enterprise Value $129.01M

Beta 3.05

Average Volume 46.09K

Shares Outstanding (Diluted) 3.54M

Shares Change YoY 452.59%

Institutional Ownership 27.55%

Exchange AMEX

ISIN US1711262048

Price Performance

Price Change 1M -9.3%

Price Change 3M -21.5%

Price Change 6M 4.8%

Price Change YTD -21.4%

Price Change 1Y -30.2%

Price Change 3Y 42.9%

Price Change 5Y 42.9%

1M CAGR (ann.) -18.4%

1Y CAGR (ann.) -30.5%

5Y CAGR (ann.) N/A

All-Time CAGR 72.1%

Valuation

PE Ratio -0.55

Forward PE 18.56

PEG Ratio 0.00

Forward PEG 0.01

PS Ratio 1.86

Forward PS 0.70

PB Ratio -53.61

P/FCF Ratio -1.89

P/Adj. FCF Ratio -1.89

P/OCF Ratio -1.94

EV/Sales 2.98

EV/EBIT -1.90

EV/EBITDA -2.05

EV/FCF -3.03

Earnings Yield -181.1%

FCF Yield -52.9%

Adj. FCF Yield -52.9%

Financial Health

Net Debt $46M

Total Debt $73.11M

Cash & Short-Term Investments $24.56M

Total Assets $137.36M

Current Ratio 1.98

Quick Ratio 1.31

Debt / Equity Ratio -48.71

Debt / EBITDA -1.16

Debt / FCF -1.72

OCF / Debt -0.58

Interest Coverage -7.81

Altman Z-Score -1.85

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 54.7%

Operating Profit Margin -133.4%

EBITDA Margin -145.6%

Net Profit Margin -165.2%

FCF Margin -98.4%

Adj. FCF Margin -98.4%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -52.1%

Return on Equity -218.9%

Return on Invested Capital -49.4%

Return on Capital Employed -54.8%

Return on Tangible Assets -95.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 150.0%

Revenue CAGR 5Y 142.6%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -31.1%

EPS CAGR 5Y -48.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y -110.5%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 3

EPS Growth Next 3Y 36.8%

Revenue Growth Next 3Y 69.2%

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$2.90

EPS Growth Est (next Q) -45.3%

Revenue Est (next Q) $17.96M

Revenue Growth Est (next Q) 142.5%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $54.50

Price Target Upside 135.4%

Cash Flow

Operating Cash Flow $-42.3M

Free Cash Flow $-42.6M

Adj. Free Cash Flow $-42.6M

FCF Per Share -$12.03

OCF Per Share -$11.95

OCF/S Ratio -97.7%

Income Statement

Revenue $43.3M

Gross Profit $23.7M

Operating Income $-57.78M

EBITDA $-63.05M

Net Income $-71.56M

EPS (Diluted) -$41.93

Revenue / Employee $470.7K

Profit / Employee $-777.79K

Employees 92